Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

4-(4-(3-(-5-Fluoro-3,4-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-5-isopropyl-1H-pyrazol-4-ylmethyl)phenyl)-N-(2-hydroxy-1,1-bis(hydroxymethyl)ethyl)-butyramide MeSH Supplementary Concept Data 2025


MeSH Supplementary
4-(4-(3-(-5-Fluoro-3,4-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-5-isopropyl-1H-pyrazol-4-ylmethyl)phenyl)-N-(2-hydroxy-1,1-bis(hydroxymethyl)ethyl)-butyramide
Unique ID
C557208
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C557208
Entry Term(s)
SAR 474832
SAR-474832
SAR474832
Registry Numbers
0
Heading Mapped to
*Glucosides
*Pyrazoles
Frequency
2
Note
inhibits sodium dependent glucose transporter SGLT1; structure in first source
Source
Eur J Pharm Sci 2011 Jan 18;42(1-2):116-29
Date of Entry
2011/04/05
Revision Date
2011/04/05
4-(4-(3-(-5-Fluoro-3,4-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-5-isopropyl-1H-pyrazol-4-ylmethyl)phenyl)-N-(2-hydroxy-1,1-bis(hydroxymethyl)ethyl)-butyramide Preferred
SAR 474832 Narrower
page delivered in 0.003s